Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Neuropharmacology

Volumn 61, Issue 3, 2011, Pages 364-381

  Halberstadt, Adam L ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT1A receptor; Drug discrimination; Hallucinogen; Head twitch; Locomotor activity; LSD; Psilocybin; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYL N,N DIPROPYLTRYPTAMINE; ALIPHATIC AMINE; BUSPIRONE; CYPROHEPTADINE; DOPAMINE RECEPTOR; GEPIRONE; GLEMANSERIN; HALOPERIDOL; INDOLEALKYLAMINE; INDOLEAMINE; IPSAPIRONE; KETAMINE; KETANSERIN; LYSERGIDE; M 100 907; MESCALINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N,N DIMETHYLTRYPTAMINE; PINDOLOL; PSILOCIN; PSILOCYBINE; PSYCHEDELIC AGENT; RISPERIDONE; RITANSERIN; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLINANSERIN; WAY 100 635; 5 METHOXY N,N DIMETHYLTRYPTAMINE; ADRENERGIC RECEPTOR; ESKETAMINE; PHENYLALKYLAMINE; RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ANXIETY DISORDER; COGNITION; CORRELATIONAL STUDY; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; EAR SCRATCH RESPONSE; EXPLORATORY BEHAVIOR; HEAD TWITCH; HUMAN; HYPERACTIVITY; MOOD; NERVE STIMULATION; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PERCEPTION; POSTSYNAPTIC POTENTIAL; PREPULSE INHIBITION; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SCRATCHING; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; STARTLE REFLEX; STRUCTURE ACTIVITY RELATION; ANIMAL BEHAVIOR; BEHAVIOR; CONCENTRATION RESPONSE; CONFERENCE PAPER; CROSS TOLERANCE; DEPRESSION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; LIGAND BINDING; LOCOMOTION; MOOD CHANGE; NERVE CELL INHIBITION; PERCEPTIVE DISCRIMINATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PSYCHOPHARMACOLOGY; RAPHE NUCLEUS; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SENSORY GATING;

ANIMALS; BEHAVIOR; BEHAVIOR, ANIMAL; HALLUCINOGENS; HUMANS; LYSERGIC ACID DIETHYLAMIDE; NERVE TISSUE PROTEINS; NEURONS; PHENETHYLAMINES; PRESYNAPTIC TERMINALS; PSILOCYBINE; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN RECEPTOR AGONISTS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 79958128516     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.01.017     Document Type: Review

References (303)

1. H.A. Abramson, A. Rolo, B. Sklarofsky, and J. Stache Production of cross-tolerance to psychosis-producing doses of lysergic acid diethylamide and psilocybin J. Psychology 49 1960 151 154
2. L. Adams, and M.A. Geyer Effects of DOM and DMT in a proposed animal model of hallucinogenic activity Prog. Neuropsychopharmacol. Biol. Psychiatry 9 1985 121 132 (Pubitemid 15089220)
3. L. Adams, and M.A. Geyer A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats Behav. Neurosci. 99 1985 881 900 (Pubitemid 15241516)
4. L. Adams, and M.A. Geyer Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide Pharmacol. Biochem. Behav. 23 1985 461 468 (Pubitemid 16256917)
5. G.K. Aghajanian, W.E. Foote, and M.E. Sheard Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe Science 161 1968 706 707
6. G.K. Aghajanian, W.E. Foote, and M.E. Sheard Action of psychotogenic drugs on midbrain raphe neurons J. Pharmacol. Exp. Ther. 171 1970 178 187
7. G.K. Aghajanian, and H.J. Haigler Hallucinogenic indoleamines: preferential action upon presynaptic serotonin receptors Psychopharmacol. Commun. 1 1975 619 629
8. G.K. Aghajanian, M.E. Sheard, and W.E. Foote LSD and mescaline: comparison of effects on single units in the midbrain raphé D.H. Efron, Psychotomimetic Drugs 1969 Raven Press New York 165 176
9. J.B. Appel, and K.A. Cunningham The use of drug discrimination procedures to characterize hallucinogenic drug actions Psychopharmacol. Bull. 22 1986 959 967 (Pubitemid 17183413)
10. J.B. Appel, M.H. Sheard, and D.X. Freedman Hallucinogen disruption of operant behavior in rats is potentiated by raphe lesions Commun. Behav. Biol. 5 1970 237 241
11. J.B. Appel, W.B. West, W.G. Rolandi, T. Alici, and K. Pechersky Increasing the selectivity of drug discrimination procedures Pharmacol. Biochem. Behav. 64 1999 353 358 (Pubitemid 29438621)
12. J.B. Appel, F.J. White, K.B. West, and A.M. Holohean Discriminative stimulus properties of ergot alkaloids F.C. Colpaert, J.L. Slangen, Drug Discrimination: Applications in CNS Pharmacology 1982 Elsevier Biomedical Press Amsterdam 49 67
13. 2 agonists in rats Pharmacol. Toxicol. 64 1989 165 172 (Pubitemid 19043605)
14. 2 agonist DOI Eur. J. Pharmacol. 161 1989 45 51 (Pubitemid 19058846)
15. V.P. Bakshi, M. Tricklebank, H.C. Neijt, V. Lehmann-Masten, and M.A. Geyer Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-d-aspartate receptor antagonists in rats J. Pharmacol. Exp. Ther. 288 1999 643 652 (Pubitemid 29119676)
16. A. Balestrieri, and D. Fontanari Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148 Arch. Gen. Psychiatry 1 1959 279 282
17. P. Bedard, and C.J. Pycock Wet-dog shake behavior in the rat: a possible quantitative model of central 5-hydroxytryptamine activity Neuropharmacology 16 1977 663 670
18. J.L. Bennett, and G.K. Aghajanian Response of single raphe neurons to (±)-LSD: correlation with (±)-LSD binding in brain J. Pharm. Pharmacol. 28 1976 516 518
19. M.A. Benneyworth, R.L. Smith, R.J. Barrett, and E. Sanders-Bush Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6 J mice Psychopharmacology (Berlin) 179 2005 854 862 (Pubitemid 40767905)
20. H.H. Berendsen, F.G. Bourgondien, and C.L. Broekkamp Role of dorsal and median raphe nuclei in lower lip retraction in rats Eur. J. Pharmacol. 263 1994 315 318 (Pubitemid 24301311)
21. H.H. Berendsen, and C.L. Broekkamp Drug-induced penile erections in rats: indications of serotonin1B receptor mediation Eur. J. Pharmacol. 135 1987 279 287 (Pubitemid 17057552)
22. H.H. Berendsen, F. Jenck, and C.L. Broekkamp Selective activation of 5HT1A receptors induces lower lip retraction in the rat Pharmacol. Biochem. Behav. 33 1989 821 827 (Pubitemid 19284295)
23. J.B. Blair, D. Kurrasch-Orbaugh, D. Marona-Lewicka, M.G. Cumbay, V.J. Watts, E.L. Barker, and D.E. Nichols Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines J. Med. Chem. 43 2000 4701 4710
24. P. Blier, and C. de Montigny Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies J. Clin. Psychopharmacol. 10 Suppl. 3 1990 13S 20S (Pubitemid 20212924)
25. P. Blier, G. Piñeyro, T. Dennis, and C. DeMontigny Electrophysiology of central serotonin neurotransmission P.M. Vanhoutte, P.R. Saxena, R. Paoletti, N. Brunello, A.S. Jackson, Serotonin: From Cell Biology to Pharmacology and Therapeutics 1993 Kluwer Academic Publishers Dordrecht 55 63
26. J. Borsey, Z. Huszeti, and M. Fekete Antimescaline properties of some lysergic acid derivatives Int. J. Neuropharmacol. 2 1964 273 277
27. R.W. Brimblecombe Effects of psychotropic drugs on open-field behavior in rats Psychopharmacology 4 1963 139 147
28. R.G. Browne The role of serotonin in the discriminative stimulus properties of mescaline B.T. Ho, D.W. Richards, D.L. Chute, Drug Discrimination and State Dependent Learning 1978 Academic Press New York 79 101
29. 2 receptor binding in rat brain Eur. J. Pharmacol. 109 1985 421 425 (Pubitemid 15108995)
30. 2 receptors in rat brain Neuropsychopharmacology 3 1990 137 148 (Pubitemid 20110905)
31. C.M. Burns, H. Chu, S. Rueter, L.K. Hutchinson, H. Canton, E. Sanders-Bush, and R.B. Emeson Regulation of serotnon-2C receptor G-protein coupling by RNA editing Nature 387 1997 303 308 (Pubitemid 27220768)
32. 1C receptor agonist J. Pharmacol. Exp. Ther. 258 1991 891 896
33. E. Calcagno, and R.W. Invernizzi Strain-dependent serotonin neuron feedback control: role of serotonin 2C receptors J. Neurochem. 114 2010 1701 1710
34. C.W. Callaway, L.L. Wing, and M.A. Geyer Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats J. Pharmacol. Exp. Ther. 254 1990 456 464 (Pubitemid 20262081)
35. C.E. Canal, U.B. Olaghere da Silva, P.J. Gresch, E.E. Watt, E. Sanders-Bush, and D.C. Airey The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen Psychopharmacology (Berlin) 209 2010 163 174
36. O.L. Carter, D.C. Burr, J.D. Pettigrew, G.M. Wallis, F. Hasler, and F.X. Vollenweider Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors J. Cogn. Neurosci. 17 2005 1497 1508 (Pubitemid 41510955)
37. O.L. Carter, F. Hasler, J.D. Pettigrew, G.M. Wallis, G.B. Liu, and F.X. Vollenweider Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans Psychopharmacology (Berlin) 195 2007 415 424 (Pubitemid 350161767)
38. G. Chen, and B. Bohner A study of certain CNS depressants Arch. Int. Pharmacodyn. 125 1960 1 20
39. M. Cohen, and H. Wakeley A comparative behavioral study of ditran and LSD in mice, rats, and dogs Arch. Int. Pharmacodyn. 173 1968 316 325
40. F.C. Colpaert Cross generalization with LSD and yohimbine in the rat Eur. J. Pharmacol. 102 1984 73 77
41. F.C. Colpaert, and P.A.J. Janssen A characterization of the LSD-antagonist effects of pirenperone in the rat Neuropharmacology 22 1983 1001 1003
42. F.C. Colpaert, G.J.E. Niemegeers, and P.A.J. Janssen A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of puported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist J. Pharmacol. Exp. Ther. 221 1982 206 214 (Pubitemid 12156493)
43. S.J. Corne, and R.W. Pickering A possible correlation between drug-induced hallucinations in man and a behavioural response in mice Psychopharmacologia 11 1967 65 78
44. S.J. Corne, R.W. Pickering, and B.T. Warnet A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine Br. J. Pharmacol. Chemother. 20 1963 106 120
45. R. Cortés, J.M. Palacios, and A. Pazos Visualization of multiple serotonin receptors in the rat brain by autoradiography Br. J. Pharmacol. 82 1984 202p
46. 1A agonists Synapse 14 1993 297 304 (Pubitemid 23231008)
47. N.V. Cozzi, A. Gopalakrishnan, L.L. Anderson, J.T. Feih, A.T. Shulgin, P.F. Daley, and A.E. Ruoho Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter J. Neural. Transm. 116 2009 1591 1599
48. 2A receptor-mediated behavior in mice during the day but not at night J. Neural. Transm. 105 1998 635 643 (Pubitemid 28454516)
49. 2 receptors? Pharmacol. Biochem. Behav. 36 1990 901 906 (Pubitemid 20272314)
50. 2-receptor interactions Pharmacol. Biochem. Behav. 37 1990 95 99 (Pubitemid 20341692)
51. N.A. Darmani, and S.L. Reeves The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice Pharmacol. Biochem. Behav. 55 1996 1 10 (Pubitemid 26285686)
52. 2 receptors Biochem. Pharmacol. 41 1991 1739 1744
53. C. de Montigny, and G.K. Aghajanian Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: a comparative iontophoretic study with LSD and serotonin Neuropharmacology 16 1977 811 818 (Pubitemid 8240497)
54. D. de Montigny, P. Blier, and Y. Chaput Electrophysiologically-identified serotonin receptors in the rat CNS Neuropharmacology 23 1984 1511 1520
55. J.F. Deegan, and L. Cook A study of the anti-mescaline property of a series of CNS-active agents in mice J. Pharmacol. Exp. Ther. 122 1958 17A
56. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampus membranes J. Pharmacol. Exp. Ther. 238 1986 248 253 (Pubitemid 16058323)
57. J.M. Doherty, V.L. Masten, S.B. Powell, R.J. Ralph, D. Klamer, M.J. Low, and M.A. Geyer Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice Neuropsychopharmacology 33 2008 2648 2656
58. S.C. Dulawa, C. Gross, K.L. Stark, R. Hen, and M.A. Geyer Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition Neuropsychopharmacology 22 2000 650 659 (Pubitemid 30219408)
59. S.C. Dulawa, R. Hen, K. Scearce-Levie, and M.A. Geyer 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice Ann. N.Y. Acad. Sci. 861 1998 79 84 (Pubitemid 29047702)
60. A. Dumuis, M. Sebben, and J. Bockaert Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture Mol. Pharmacol. 33 1988 178 186 (Pubitemid 18068125)
61. 2C receptors Psychopharmacology 136 1998 409 414 (Pubitemid 28189672)
62. A.S. Eison, and R.N. Wright 5-HT1A and 5-HT2 receptors mediate discrete behaviors in the Mongolian gerbil Pharmacol. Biochem. Behav. 43 1992 131 137
63. W.E. Fantegrossi, A.W. Harrington, J.R. Eckler, S. Arshad, R.A. Rabin, J.C. Winter, A. Coop, K.C. Rice, and J.H. Woods Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats Psychopharmacology (Berlin) 181 2005 496 503 (Pubitemid 41480898)
64. W.E. Fantegrossi, A.W. Harrington, C.L. Kiessel, J.R. Eckler, R.A. Rabin, J.C. Winter, A. Coop, K.C. Rice, and J.H. Woods Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats Pharmacol. Biochem. Behav. 83 2006 122 129
65. W.E. Fantegrossi, C.J. Reissig, E.B. Katz, H.L. Yarosh, K.C. Rice, and J.C. Winter Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents Pharmacol. Biochem. Behav. 88 2008 358 365 (Pubitemid 350123552)
66. W.E. Fantegrossi, J. Simoneau, M.S. Cohen, S.M. Zimmerman, C.M. Henson, K.C. Rice, and J.H. Woods Interaction of 5-HT2A and 5-HT2C receptors in DOI-elicited head twitch behavior in mice J. Pharmacol. Exp. Ther. 2010 10.1124/jpet.110.172247
67. 2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine Psychopharmacology 122 1995 237 243
68. 2C receptors in the stimulus effects of hallucinogenic drugs I: antagonist correlation analysis Psychopharmacology 121 1995 347 356
69. 2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives Psychopharmacology 121 1995 357 363
70. 2C receptor knockout mice Neuropharmacology 57 2009 259 267
71. D. Fontanilla, M. Johannessen, A.R. Hajipour, N.V. Cozzi, M.B. Jackson, and A.E. Ruoho The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator Science 323 2009 934 937
72. 1A agonist and antagonist drug administration in behaving cats J. Pharmacol. Exp. Ther. 270 1994 1345 1358 (Pubitemid 24315260)
73. 2A receptor agonist TCB-2: a behavioral and neurophysiological analysis Psychopharmacology (Berlin) 212 2009 13 23
74. J.R. Fozard, E.J. Kidd, J. Neill, and M. Tricklebank Further characterisation of the discriminative stimulus induced by 8-hydroxy-2-(di-n- propylamino) tetralin in rats Br. J. Pharmacol. 88 1986 371P
75. D.X. Freedman LSD: the bridge from human to animal B.L. Jacobs, Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives 1984 Raven Press New York 203 226
76. D.W. Gallager, and G.K. Aghajanian Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow J. Pharmacol. Exp. Ther. 193 1975 785 795
77. S. Gershon, and J. Olariu JB 329 - a new psychotomimetic. Its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline, and sernyl J. Neuropsychiat. 1 1960 283 292
78. M.A. Geyer Variational and probabalistic aspects of exploratory behavior in space: four stimulant styles Psychopharmacol. Bull. 18 1982 48 51 (Pubitemid 13211154)
79. M.A. Geyer Approaches to the characterization of drug effects on locomotor activity in rodents M.W. Adler, A. Cowan, Modern Methods in Pharmacology: Testing and Evaluation of Drugs of Abuse 1990 Wiley-Liss New York 81 99
80. M.A. Geyer, and C.W. Callaway Behavioral pharmacology of ring-substituted amphetamine analogs A.K. Cho, D.S. Segal, Amphetamine and its Analogs: Neuropsychopharmacology Toxicology and Abuse 1994 Academic Press New York 177 208
81. M.A. Geyer, and M.P. Paulus Multivariate and nonlinear approaches to characterizing drug effects on the locomotor and investigatory behavior of rats NIDA Res. Monogr. 124 1992 203 235 (Pubitemid 23081983)
82. M.A. Geyer, and M.P. Paulus Multivariate analyses of locomotor and investigatory behavior in rodents K.P. Ossenkopp, M. Kavaliers, P.R. Sanberg, Measuring Movement and Locomotion: From Invertebrates to Humans 1996 R.G. Landes Co 253 271
83. M.A. Geyer, G.J. Rose, and L.R. Petersen Mescaline increases startle responding equally in normal and raphe-lesioned rats Pharmacol. Biochem. Behav. 10 1979 293 298 (Pubitemid 9134177)
84. M.A. Geyer, P.V. Russo, and V.L. Masten Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses Pharmacol. Biochem. Behav. 25 1986 277 288 (Pubitemid 16040937)
85. M.A. Geyer, P.V. Russo, D.S. Segal, and R. Kuczenski Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats Pharmacol. Biochem. Behav. 28 1987 393 399 (Pubitemid 18002792)
86. M.A. Geyer, and F.X. Vollenweider Serotonin research: contributions to understanding psychoses Trends Pharmacol. Sci. 29 2008 445 453
87. 1A agonist 8-hydroxy-2-(di- n-propylamino)tetralin (8-OH DPAT) Pharmacol. Biochem. Behav. 25 1986 135 139 (Pubitemid 16040915)
88. R.A. Glennon Site-selective serotonin agonists as discriminative stimuli F.C. Colpaert, R. Balster, Transduction Mechanisms of Drug Stimuli 1988 Springer-Verlag Berlin 16 31
89. 2 agonists or antagonists? Neuropsychopharmacology 3 1990 509 517
90. R.A. Glennon Discriminative stimulus properties of hallucinogens and related designer drugs NIDA Res. Monogr. 116 1991 25 44 (Pubitemid 23089661)
91. R.A. Glennon, M. Dukat, M. El-Bermawy, H. Law, J. De Los Angeles, M. Teitler, A. King, and K. Herrick-Davis Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines J. Med. Chem. 37 1994 1929 1935 (Pubitemid 24233604)
92. R.A. Glennon, R. Raghupathi, P. Bartyzel, M. Teitler, and S. Leonhardt Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity J. Med. Chem. 35 1992 734 740
93. R.A. Glennon, J.A. Rosecrans, and R. Young The use of the drug discrimination paradigm for studying hallucinogenic agents. A review F.C. Colpaert, J.L. Slangen, Drug Discrimination: Applications in CNS Pharmacology 1982 Elsevier Biomedical Press Amsterdam 69 96
94. R.A. Glennon, J.A. Rosecrans, and R. Young Drug-induced discrimination: a description of the paradigm and a review of its application in the study of hallucinogenic agents Med. Res. Rev. 3 1983 289 340 (Pubitemid 13047821)
95. R.A. Glennon, J.A. Rosecrans, R. Young, and J. Gaines Hallucinogens as discriminative stimuli Life Sci. 24 1979 993 998
96. R.A. Glennon, M. Titeler, R.A. Lyon, and R.M. Slusher N,N-Di-n-propylserotonin: binding at serotonin binding sites and a comparision with 8-hydroxy-2-(di- n-propylamino)tetralin J. Med. Chem. 31 1988 867 870 (Pubitemid 18097112)
97. 2 involvement in the mechanisms of action of hallucinogenic agents Life Sci. 35 1984 2505 2511 (Pubitemid 15212191)
98. R.A. Glennon, M. Titeler, and E. Sanders-Bush Hallucinogens and serotonergic mechanisms NIDA Res. Monogr. 119 1992 131 135
99. R.A. Glennon, M. Titeler, and R. Young Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies Psychopharmacol. Bull. 22 1986 953 958 (Pubitemid 17183412)
100. 2 antagonists Eur. J. Pharmacol. 91 1983 189 196 (Pubitemid 13029226)
101. A. Gogos, M. Bogeski, and M. van den Buuse Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology Behav. Pharmacol. 19 2008 548 561
102. L.H. Gold, C.B. Hubner, and G.F. Koob A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA Psychopharmacology 99 1989 40 47 (Pubitemid 19201712)
103. L.H. Gold, G.F. Koob, and M.A. Geyer Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats J. Pharmacol. Exp. Ther. 247 1988 547 555
104. 2A receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452 (Pubitemid 46161267)
105. E. Gouzoulis-Mayfrank, K. Heekeren, A. Neukirch, M. Stoll, C. Stock, M. Obradovic, and K.A. Kovar Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers Pharmacopsychiatry 38 2005 301 311 (Pubitemid 41815687)
106. E. Gouzoulis-Mayfrank, K. Heekeren, B. Thelen, H. Lindenblatt, K.A. Kovar, H. Sass, and M.A. Geyer Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans Behav. Pharmacol. 9 1998 561 566 (Pubitemid 28552549)
107. E. Gouzoulis-Mayfrank, B. Thelen, E. Habermeyer, H.J. Kunert, K.A. Kovar, L. Hermle, M. Spitzer, and H. Sass Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study Psychopharmacology 142 1999 41 50 (Pubitemid 29196062)
108. D.G. Grahame-Smith Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan J. Neurochem. 18 1971 1053 1066
109. P.J. Gresch, R.J. Barrett, E. Sanders-Bush, and R.L. Smith 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide J. Pharmacol. Exp. Ther. 320 2007 662 669 (Pubitemid 46147946)
110. R.R. Griffiths, W.A. Richards, U. McCann, and R. Jesse Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology (Berlin) 187 2006 268 283 (Pubitemid 44088380)
111. C.S. Grob, A.L. Danforth, G.S. Chopra, M.C. Hagerty, A.L. Halberstadt, and C.R. McKay A pilot study of psilocybin treatment for anxiety in advanced-stage cancer patients Arch. Gen. Psychiatry 68 2011 71 78
112. 2C receptor RNA editing in the amygdala of C57BL/6 J, DBA/2 J, and BALB/cJ mice Neurosci. Res. 55 2006 96 104 (Pubitemid 43670501)
113. H.J. Haigler, and G.K. Aghajanian Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain Eur. J. Pharmacol. 21 1973 53 60
114. H.J. Haigler, and G.K. Aghajanian Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input J. Pharmacol. Exp. Ther. 188 1974 688 699
115. A.L. Halberstadt, M.R. Buell, V.L. Masten, V.B. Risbrough, and M.A. Geyer Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors Psychopharmacology (Berlin) 201 2008 55 66
116. 2A receptor Psychopharmacology 208 2010 179 189
117. A.L. Halberstadt, L. Koedood, S.B. Powell, and M.A. Geyer Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice J. Psychopharmacol 2010 10.1177/0269881110388326
118. A.L. Halberstadt, and D.E. Nichols Serotonin and serotonin receptors in hallucinogen action C. Muller, B. Jacobs, Handbook of the Behavioral Neurobiology of Serotonin 2010 Academic London 621 636
119. 2C receptors exert opposing effects on locomotor activity in mice Neuropsychopharmacology 34 2009 1958 1967
120. R. Hameleers, A. Blokland, H.W. Steinbusch, V. Visser-Vandewalle, and Y. Temel Hypomobility after DOI administration can be reversed by subthalamic nucleus deep brain stimulation Behav. Brain Res. 185 2007 65 67 (Pubitemid 47552576)
121. J.C.P. Heaton, and S.L. Handley Comparision of DOI-induced scratching and head-twitch behaviors: differential action of 8-OH-DPAT Br. J. Pharmacol. 98 1989 687P
122. K. Heekeren, A. Neukirch, J. Daumann, M. Stoll, M. Obradovic, K.A. Kovar, M.A. Geyer, and E. Gouzoulis-Mayfrank Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N- dimethyltryptamine (DMT) models of psychosis J. Psychopharmacol. 21 2007 312 320 (Pubitemid 46934051)
123. 1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatment Neuropsychopharmacology 4 1991 131 144
124. L. Hermle, M. Funfgeld, G. Oepen, H. Botsch, D. Borchardt, E. Gouzoulis, R.A. Fehrenbach, and M. Spitzer Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research Biol. Psychiatry. 32 1992 976 991 (Pubitemid 23026372)
125. L. Hermle, E. Gouzoulis-Mayfrank, and M. Spitzer Blood flow and cerebral laterality in the mescaline model of psychosis Pharmacopsychiatry 31 Suppl 2 1998 85 91 (Pubitemid 28396277)
126. 1D receptor in rat and human brain J. Neurochem. 50 1988 1624 1631
127. W.M. Herrmann, R. Horowski, K. Dannehl, V. Kramer, and K. Lurati Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide Headache 17 1977 54 60 (Pubitemid 8111146)
128. J. Heym, K. Rasmussen, and B.L. Jacobs Some behavioral effects of hallucinogens are mediated by postsynaptic serotonergic action: evidence from single unit studies in freely moving cats Eur. J. Pharmacol. 101 1984 57 68 (Pubitemid 14117883)
129. I.D. Hirschhorn, and J.C. Winter Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli Psychopharmacologia (Berlin) 22 1971 64 71
130. S. Hjorth, A. Carlsson, P. Lindberg, D. Sanchez, H. Wikdtrom, L.E. Arvidsson, U. Hacksell, and J.L.G. Nilsson 8-Hydroxy-2-(di-n-propylamino) tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity J. Neural. Transm. 55 1982 169 188 (Pubitemid 13205903)
131. L.E. Hollister, M.F. Macnicol, and H.K. Gillespie A hallucinogenic amphetamine analog (DOM) in man Psychopharmacologia 14 1969 62 73
132. 1 recognition sites J. Receptor Res. 8 1988 59 81
133. 1C receptors Trends Pharmacol. Sci. 9 1988 89 94 (Pubitemid 18072556)
134. 3H]5-HT binding Neurosci. Lett. 69 1986 269 274 (Pubitemid 16012090)
135. X. Huang, D. Marona-Lewicka, R.C. Pfaff, and D.E. Nichols Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives Pharmacol. Biochem. Behav. 47 1994 667 673 (Pubitemid 24077738)
136. H. Isbell Comparison of the reactions induced by psilocybin and LSD-25 in man Psychopharmacologia (Berlin) 1 1959 29 38
137. H. Isbell, A.B. Wolbach, A. Wikler, and E.J. Miner Cross tolerance between LSD and psilocybin Psychopharmacologia (Berlin) 2 1961 147 159
138. 1C-selective antagonist J. Med. Chem. 36 1993 2519 2525 (Pubitemid 23270802)
139. B.L. Jacobs An overview of brain serotonergic unit activity and its relavence to the neuropharmacology of serotonin A.R. Green, Neuropharmacology of Serotonin 1985 Oxford University Press Oxford 211 212
140. T.U. Jarbe LSD-25 as a discriminative stimulus for response selection by pigeons Pharmacol. Biochem. Behav. 13 1980 549 554 (Pubitemid 10024773)
141. C. Johansson, D.M. Jackson, J. Zhang, and L. Svensson Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats Pharmacol. Biochem. Behav. 52 1995 649 654
142. R.J. Joordens, T.H. Hijzen, and B. Olivier The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response Psychopharmacology (Berlin) 139 1998 383 390 (Pubitemid 28435035)
143. J. Kabes, Z. Fink, and Z. Roth A new device for measuring spontaneous motor activity - effects of lysergic acid diethylamide in rats Psychopharmacologia 23 1972 75 85
144. M.J. Keiser, V. Setola, J.J. Irwin, C. Laggner, A.I. Abbas, S.J. Hufeisen, N.H. Jensen, M.B. Kuijer, R.C. Matos, T.B. Tran, R. Whaley, R.A. Glennon, J. Hert, K.L. Thomas, D.D. Edwards, B.K. Shoichet, and B.L. Roth Predicting new molecular targets for known drugs Nature 462 2009 175 181
145. B.A. Killinger, M.M. Peet, and L.E. Baker Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats Pharmacol. Biochem. Behav. 96 2010 260 265
146. 2A/2C antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats J. Pharmacol. Exp. Ther. 282 1997 747 759 (Pubitemid 27340175)
147. W. Koek, and F.C. Colpaert Receptor mechanisms of the discriminative stimulus properties of putative serotonin agonists P. Bevan, A.R. Cools, T. Archer, Behavioral Pharmacology of 5-HT 1989 Lawrence Erlbaum Associates Hillsdale, New Jersey 407 424
148. 1C receptors Neurosci. Biobehav. Rev. 16 1992 95 105
149. K.M. Krebs, and M.A. Geyer Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats Psychopharmacology (Berlin) 113 1994 429 437 (Pubitemid 24150490)
150. 1A receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats Behav. Pharmacol. 7 1996 551 559
151. 2C receptors Neuropsychopharmacology 18 1998 339 351 (Pubitemid 28140659)
152. 2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats Psychopharmacology 189 2006 319 329 (Pubitemid 44772815)
153. D.M. Kuhn, F.J. White, and J.B. Appel The discriminative stimulus properties of LSD: mechanisms of action Neuropharmacology 17 1978 257 263 (Pubitemid 8318545)
154. A.S. Kulkarni Scratching response induced in mice by mescaline and related amphetamine derivatives Biol. Psychiatry 6 1973 177 180
155. J.P. Laurent, and J. Pieri Lisuride and LSD decrease spontaneous firing
156. E.H.Y. Lee, and M.A. Geyer Persistant effects of chronic administration of LSD on intracellular serotonin content in rat midbrain Neuropharmacology 19 1980 1005 1007 (Pubitemid 10061550)
157. V.D. Lehmann-Masten, and M.A. Geyer Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats Neuropharmacology 30 1991 629 636
158. J.E. Leysen Use of 5-HT receptor agonists and antagonists for the characterization of their respective receptor sites A.A. Boulton, G.B. Bakar, A.V. Juorio, Drugs As Tools In Neurotransmitter Research, Neuromethods vol. 12 1989 Humana Press, Clifton, New Jersey 299 350
159. 2 receptor studies Neuropsychopharmacology 3 1990 361 369
160. 2 receptors by DOM treatment Eur. J. Pharmacol. 163 1989 145 149 (Pubitemid 19107556)
161. 3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role Mol. Pharmacol. 21 1982 301 314 (Pubitemid 12139828)
162. J.X. Li, K.C. Rice, and C.P. France Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity Behav. Pharmacol. 18 2007 283 288 (Pubitemid 46884164)
163. J.X. Li, K.C. Rice, and C.P. France Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys J. Pharmacol. Exp. Ther. 324 2008 827 833 (Pubitemid 351185829)
164. J.X. Li, K.C. Rice, and C.P. France Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses J. Pharmacol. Exp. Ther. 328 2009 976 981
165. I. Lucki, M.S. Nobler, and A. Frazer Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat J. Pharmacol. Exp. Ther. 228 1984 133 139 (Pubitemid 14223392)
166. C. Mannoury La Cour, S. El Mestikawy, N. Hanoun, M. Hamon, and L. Lanfumey Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain Mol. Pharmacol. 70 2006 1013 1021 (Pubitemid 44268458)
167. D. Marona-Lewicka, B.R. Chemel, and D.E. Nichols Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI Psychopharmacology (Berlin) 203 2009 265 277
168. D. Marona-Lewicka, D.M. Kurrasch-Orbaugh, J.R. Selken, M.G. Cumbay, J.G. Lisnicchia, and D.E. Nichols Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats Psychopharmacology (Berlin) 164 2002 93 107 (Pubitemid 35203846)
169. 2-adrenoceptor agonists and antagonists Psychopharmacology 120 1995 384 391
170. D. Marona-Lewicka, and D.E. Nichols Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action Pharmacol. Biochem. Behav. 87 2007 453 461 (Pubitemid 47243674)
171. D. Marona-Lewicka, R.A. Thisted, and D.E. Nichols Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis Psychopharmacology (Berlin) 180 2005 427 435 (Pubitemid 40905032)
172. K.L. Marquis, A.L. Sabb, S.F. Logue, J.A. Brennan, M.J. Piesla, T.A. Comery, S.M. Grauer, C.R. Ashby Jr., H.Q. Nguyen, L.A. Dawson, J.E. Barrett, G. Stack, H.Y. Meltzer, B.L. Harrison, and S. Rosenzweig-Lipson WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[ 6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity J. Pharmacol. Exp. Ther. 320 2007 486 496 (Pubitemid 46025760)
173. J.R. Martin, M. Bos, F. Jenck, J. Moreau, V. Mutel, A.J. Sleight, J. Wichmann, J.S. Andrews, H.H. Berendsen, C.L. Broekkamp, G.S. Ruigt, C. Kohler, and A.M. Delft 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential J. Pharmacol. Exp. Ther. 286 1998 913 924 (Pubitemid 29003485)
174. 2 receptors in rat brain Neuropsychopharmacology 2 1989 81 87 (Pubitemid 19126163)
175. D.J. McKenna, D.B. Repke, L. Lo, and S.J. Peroutka Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes Neuropharmacology 29 1990 193 198 (Pubitemid 20096380)
176. T.H. McLean, J.C. Parrish, M.R. Braden, D. Marona-Lewicka, A. Gallardo-Godoy, and D.E. Nichols 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists J. Med. Chem. 49 2006 5794 5803 (Pubitemid 44423716)
177. T.F. Meert Serotonin mechanisms in antipsychotic treatment: evidence from drug discrimination studies J.M. Kane, H.J. Möller, F. Awouters, Serotonin in Antipsychotic Treatment. Mechanisms and Clinical Practice 1996 Marcel Dekker, Inc New York 109 130
178. 2 antagonists: a preclinical evaluation of possible therapeutic effects C. Idzikowski, P.J. Cowen, Serotonin, Sleep and Mental Disorders 1991 Biomedical Publishing Washington 65 76
179. T.F. Meert, P. DeHaes, and P.A.J. Janssen Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats Psychopharmacology 97 1989 206 212 (Pubitemid 19040163)
180. T.F. Meert, P.L.A.J. DeHaes, P.C.M. Vermote, and P.A.J. Janssen Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat Drug Dev. Res. 19 1990 353 373 (Pubitemid 20150262)
181. G. Mengod, M.T. Vilaró, A. Raurich, J.F. López- Giménez, R. Cortés, and J.M. Palacios 5-HT receptors in mammalin brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors Histochem. J. 28 1996 747 758 (Pubitemid 26414165)
182. 2A serotonin receptor binding J. Med. Chem. 41 1998 5084 5093 (Pubitemid 28555465)
183. M.J. Millan, L. Maiofiss, D. Cussac, V. Audinot, J.A. Boutin, and A. Newman-Tancredi Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes J. Pharmacol. Exp. Ther. 303 2002 791 804 (Pubitemid 35231256)
184. D.J. Minnema, and J.A. Rosecrans Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions Pharmacol. Biochem. Behavior. 20 1984 95 101 (Pubitemid 14181989)
185. S.M. Mittman, and M.A. Geyer Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens Psychopharmacology (Berlin) 98 1989 321 329 (Pubitemid 19162419)
186. S.M. Mittman, and M.A. Geyer Disassociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol Psychopharmacology 105 1991 69 76
187. A.P. Monte, D. Marona-Lewicka, A. Kanthasamy, E. Sanders-Bush, and D.E. Nichols Stereoselective LSD-like activity in a series of d-lysergic acid amides (R)- and (S)-2-aminoalkanes J. Med. Chem. 38 1995 958 966
188. F.A. Moreno, C.B. Wiegand, E.K. Taitano, and P.L. Delgado Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder J. Clin. Psychiatry 67 2006 1735 1740 (Pubitemid 44955154)
189. S.S. Mosko, and B.L. Jacobs Electrophysiological evidence against negative neuronal feedback from the forebrain controlling midbrain raphe unit activity Brain Res. 119 1977 291 303 (Pubitemid 8006248)
190. J. Mos, B. Olivier, and M.Th.M. Tulp Ethopharmacological studies differentiate the effects of various serotonergic compounds on agression in rats Drug Dev. Res. 26 1992 343 360
191. F. Nagai, R. Nonaka, and K. Satoh Hisashi Kamimura The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain Eur. J. Pharmacol. 559 2007 132 137 (Pubitemid 46295399)
192. 2C receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 359 1999 1 6 (Pubitemid 29142561)
193. 2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs J. Neurochem. 67 1996 2521 2531 (Pubitemid 26392524)
194. D.E. Nichols Role of serotonergic neurons and 5-HT receptors in the action of hallucinogens H.G. Baumgarten, M. Göthert, Serotonergic Neurons and 5-HT Receptors in the CNS: Handbook of Experimental Pharmacology vol. 129 1997 Springer-Verlag Berlin 563 585
195. D.E. Nichols Hallucinogens Pharmacol. Ther. 101 2004 131 181 (Pubitemid 38167565)
196. D.E. Nichols, S. Frescas, D. Marona-Lewicka, and D.M. Kurrasch-Orbaugh Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N- diethyllysergamide (LSD) J. Med. Chem. 45 2002 4344 4349 (Pubitemid 35025580)
197. A. Ouagazzal, A.J. Grottick, J. Moreau, and G.A. Higgins Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains Neuropsychopharmacology 25 2001 565 575 (Pubitemid 32830961)
198. 2 agonist, (±)-1-(2,5-dimethoxy-4- bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration J. Pharmacol. Exp. Ther. 256 1991 795 800
199. T. Pálenícek, M. Balíková, V. Bubeníková-Valesová, and J. Horácek Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose Psychopharmacology (Berlin) 196 2008 51 62
200. M.A. Parker, D. Marona-Lewicka, V.L. Lucaites, D.L. Nelson, and D.E. Nichols A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor J. Med. Chem. 41 1998 5148 5149 (Pubitemid 29016308)
201. M.P. Paulus, and M.A. Geyer The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity Neuropsychopharmacology 7 1992 15 31
202. P.J. Pauwels, P. Van Gompel, and J.E. Leysen Activity of serotonin (5-HT) receptor agonists, partial agonists, and antagonists at cloned human 5-HT1A receptors that are negatively linked to adenylate cyclase in permenantely transfected HeLa cells Biochem. Pharmacol. 45 1993 375 383 (Pubitemid 23042636)
203. A. Pazos, D. Hoyer, and J.M. Palacios The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site Eur. J. Pharmacol. 106 1984 539 546 (Pubitemid 15194103)
204. A. Pazos, and J.M. Palacios Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors Brain Res. 346 1985 205 230 (Pubitemid 16241111)
205. N.J. Penington Actions of methoxylated amphetamine hallucinogens on serotonergic neurons of the brain Prog. Neuropsychopharmacol. Biol. Psychiatry 20 1996 951 965 (Pubitemid 26300465)
206. N.J. Penington, and R.J. Reiffenstein Direct comparision of hallucinogenic phenethylamines and d-amphetamine on dorsal raphe neurons Eur. J. Pharmacol. 122 1986 373 377 (Pubitemid 16061486)
207. 1C binding sites in rat frontal cortex J. Neurochem. 47 1986 529 540 (Pubitemid 16052871)
208. S.J. Peroutka 5-Hydroxytryptamine receptor interactions of d-lysergic acid diethylamide A. Pletscher, D. Ladewig, 50 Years of LSD. Current Status and Perspectives of Hallucinogens 1994 Parthenon Press New York 19 26
209. S.J. Peroutka, R.M. Lebovitz, and S.H. Snyder Two distinct central serotonin receptors with different physiological functions Science 212 1981 827 829 (Pubitemid 11069388)
210. S.J. Peroutka, and S.H. Snyder Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol Mol. Pharmacol. 16 1979 687 699 (Pubitemid 10203525)
211. P.A. Pierce, and S.J. Peroutka Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex Psychopharmacology 97 1989 118 122 (Pubitemid 19020394)
212. L. Pieri, H.H. Keller, and J.P. Laurent Behavioral, neurochemical, and electrophysiological effects of lisuride and LSD in animals D.B. Calne, Lisuride and other Dopamine Agonists 1983 Raven Press New York 89 96
213. 1A receptor in the rat brain: correlation with receptor binding J. Neurosci. 12 1992 440 453
214. 2C receptors in CHO-K1 cells Br. J. Pharmacol. 128 1999 13 20 (Pubitemid 29425262)
215. S. Powell, V. Risbrough, V. Lehmann-Masten, K. Krebs-Thomson, R. Hen, J. Gingrich, and M. Geyer The indoleamine hallucinogens, psilocin and 5MeO-DMT, increase prepulse inhibition in mice: role of 5HT1A and 5HT2A receptors Soc. Neurosci. Abstr. 2003 315.7
216. 1A binding sites in rats with chronic neonatal 5,7-dihydroxytryptamine lesions Dev. Brain Res. 80 1994 1 6
217. B.B. Quednow, M.A. Geyer, and A.L. Halberstadt Serotonin and schizophrenia C.P. Muller, B. Jacobs, Handbook of the Behavioral Neurobiology of Serotonin 2010 Academic Press London 585 620
218. 2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo Br. J. Pharmacol. 158 2009 1477 1485
219. R.J. Ralph-Williams, V. Lehmann-Masten, V. Otero-Corchon, M.J. Low, and M.A. Geyer Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice J. Neurosci. 22 2002 9604 9611 (Pubitemid 35356202)
220. C.J. Reissig, J.R. Eckler, R.A. Rabin, and J.C. Winter The 5-HT1A receptor and the stimulus effects of LSD in the rat Psychopharmacology (Berlin) 182 2005 197 204 (Pubitemid 41464612)
221. N.L. Rempel, C.W. Callaway, and M.A. Geyer Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release Neuropsychopharmacology 8 1993 201 211 (Pubitemid 23151387)
222. J. Riba, A. Rodríguez-Fornells, and M.J. Barbanoj Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively Psychopharmacology (Berlin) 165 2002 18 28 (Pubitemid 36044727)
223. 1a receptor agonists block prepulse inhibition of acoustic startle reflex J. Pharmacol. Exp. Ther. 263 1992 486 493
224. V.B. Risbrough, V.L. Masten, S. Caldwell, M.P. Paulus, M.J. Low, and M.A. Geyer Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice Neuropsychopharmacology 31 2006 2349 2358 (Pubitemid 44607051)
225. M.A. Rogawski, and G.K. Aghajanian Response of central monoaminergic neurons to lisuride: comparison with LSD Life Sci. 24 1979 1289 1298
226. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain Neuropsychopharmacology 15 1996 349 360 (Pubitemid 26342918)
227. D.E. Rosenberg, H. Isbell, E.J. Miner, and C.R. Logan The effects of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide Psychopharmacologia 5 1964 217 227
228. D.E. Rosenberg, A.B. Wolbach, E.J. Miner, and H. Isbell Observations of direct and cross tolerance with LSD and d-amphetamine in man Psychopharmacologia 5 1963 1 15
229. E. Sanders-Bush, and P.J. Conn Effector systems coupled to serotonin receptors in brain: serotonin stimulated phosphoinositide hydrolysis Psychopharmacol. Bull. 22 1986 829 836 (Pubitemid 17183391)
230. 2 receptor: implications for treating LSD-induced hallucinogenesis Psychopharmacology 98 1989 495 499 (Pubitemid 19193897)
231. C. Sanchez, J. Arnt, and E. Moltzen Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models Eur. J. Pharmacol. 315 1996 245 254 (Pubitemid 26414269)
232. 1C receptor agonists: what next? NIDA Res. Monogr. 146 1994 203 213
233. E. Sanders-Bush, K.D. Burris, and K. Knoth Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysys J. Pharmacol. Exp. Ther. 246 1988 924 928
234. 1A receptors Psychopharmacology 108 1992 85 92
235. 1A agonists J. Pharmacol. Exp. Ther. 273 1995 101 112
236. R. Schreiber, M. Brocco, and M.J. Millan Blockade of the discriminative stimulus effect of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone Eur. J. Pharmacol. 264 1994 99 102 (Pubitemid 24310841)
237. 1A receptor agonists in the rat J. Pharmacol. Exp. Ther. 265 1993 572 579 (Pubitemid 23315560)
238. R.E. Schultes, and A. Hofmann The Botany and Chemistry of Hallucinogens 1980 Charles C. Thomas Springfield
239. P.A. Scott, J.M. Chou, H. Tang, and A. Frazer Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists J. Pharmacol. Exp. Ther. 270 1994 198 208
240. P. Seeman, H.C. Guan, and H. Hirbec Dopamine D2high receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil Synapse 63 2009 698 704
241. A. Shulgin, and A. Shulgin PIHKAL: A Chemical Love Story 1991 Transform Press Berkeley, CA
242. A. Shulgin, and A. Shulgin TiHKAL: The Continuat Ion 1997 Transform Press Berkeley, CA
243. M.T.A. Silva, and H.M. Calil Screening hallucinogenic drugs: systematic study of three behavioral tests Psychopharmacologia 42 1975 163 171
244. T.A. Sipes, and M.A. Geyer Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats Neuropharmacology 33 1994 441 448 (Pubitemid 24168715)
245. 2C receptors Behav. Pharmacol. 6 1995 839 842
246. T.A. Sipes, and M.A. Geyer 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action Psychopharmacology (Berlin) 117 1995 41 48
247. T.A. Sipes, and M.A. Geyer DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum Brain Res. 761 1997 97 104 (Pubitemid 27314738)
248. R.S. Sloviter, E.G. Drust, and J.D. Connor Specificity of a rat behavioral model for serotonin receptor activation J. Pharmacol. Exp. Ther. 206 1978 339 347 (Pubitemid 9041314)
249. L.M. Smith, and S.J. Peroutka Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome Pharmacol. Biochem. Behav. 24 1986 1513 1519 (Pubitemid 16066606)
250. 2C, receptor Psychopharmacology 144 1999 248 254 (Pubitemid 29307276)
251. R.L. Smith, R.J. Barrett, and E. Sanders-Bush Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6 J mice Psychopharmacology (Berlin) 166 2003 61 68 (Pubitemid 36286721)
252. 2C receptors Pharmacol. Biochem. Behav. 61 1998 323 330 (Pubitemid 28498215)
253. S.R. Smith, W.A. Prosser, D.J. Donahue, M.E. Morgan, C.M. Anderson, and W.R. Shanahan Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women Obesity (Silver Spring) 17 2009 494 503
254. S.R. Smith, N.J. Weissman, C.M. Anderson, M. Sanchez, E. Chuang, S. Stubbe, H. Bays, and W.R. Shanahan Multicenter, placebo-controlled trial of lorcaserin for weight management N. Engl. J. Med. 363 2010 245 256
255. S.H. Snyder, L. Faillace, and L. Hollister 2,5-Dimethoxy-4-methyl- amphetamine (STP): a new hallucinogenic drug Science 158 1967 669 670
256. C. Sogawa, N. Sogawa, J. Tagawa, A. Fujino, K. Ohyama, M. Asanuma, M. Funada, and S. Kitayama 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter Toxicol. Lett. 170 2007 75 82 (Pubitemid 46498906)
257. D.G. Spencer, T. Glaser, and J. Traber Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine Psychopharmacology 93 1987 158 166 (Pubitemid 18013050)
258. 1A receptors Psychopharmacology 91 1987 25 29 (Pubitemid 17000883)
259. 1B agonists Synapse 1 1985 3 9
260. R. Strassman DMT: The Spirit Molecule 2001 Park Street Press Rochester
261. R.J. Strassman Human psychopharmacology of N,N-dimethyltryptamine Behav. Brain Res. 73 1996 121 124 (Pubitemid 26008771)
262. R.J. Strassman, and C.R. Qualls Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects Arch. Gen. Psychiatry 51 1994 85 97 (Pubitemid 24054310)
263. R.J. Strassman, C.R. Qualls, E.H. Uhlenhuth, and R. Kellner Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale Arch. Gen. Psychiatry 51 1994 98 108 (Pubitemid 24054311)
264. H.V. Thiagaraj, E.B. Russo, A. Burnett, E. Goldstein, C.M. Thompson, and K.K. Parker Binding properties of dipropyltryptamine at the human 5-HT1a receptor Pharmacology 74 2005 193 199 (Pubitemid 41022581)
265. 2 receptor as a site of action for LSD and phenylisopropyl amine hallucinogens Psychopharmacology 94 1988 213 216 (Pubitemid 18040697)
266. M.D. Tricklebank, C. Forler, and J.R. Fozard The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat Eur. J. Pharmacol. 106 1984 271 282 (Pubitemid 15210616)
267. M.D. Tricklebank, C. Forler, D.N. Middlemiss, and J.R. Fozard Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-N,N- dimethyltryptamine in the rat Eur. J. Pharmacol. 117 1985 15 24 (Pubitemid 16204495)
268. M.E. Trulson Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats Pharmacol. Biochem. Behav. 24 1986 351 357 (Pubitemid 16185607)
269. M.E. Trulson, J. Heym, and B.L. Jacobs Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats Brain Res. 215 1981 275 293 (Pubitemid 11123247)
270. M.E. Trulson, and B.L. Jacobs Alterations of serotonin and LSD receptor binding following repeated administration of LSD Life Sci. 24 1979 2053 2062 (Pubitemid 10229689)
271. M.E. Trulson, and B.L. Jacobs Dissociations between the effects of LSD on behavior and raphe unit activity in freely moving cats Science 205 1979 515 518 (Pubitemid 9232781)
272. M.E. Trulson, C.A. Ross, and B.L. Jacobs Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD Psychopharmacol. Commun. 2 1976 149 164 (Pubitemid 8153698)
273. M.E. Trulson, C.A. Ross, and B.L. Jacobs Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide Neuropharmacology 16 1977 771 774 (Pubitemid 8200704)
274. P.A. Tueting, J. Metz, B.K. Rhoades, and N.N. Boutros Pharmacologic challenge in ERP research Ann. N.Y. Acad. Sci. 658 1992 223 255
275. C.P. VanderMaelen, G.K. Matheson, R.C. Wilderman, and L.A. Patterson Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug Eur. J. Pharmacol. 129 1986 123 130 (Pubitemid 16033014)
276. G.B. Varty, and G.A. Higgins Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs Psychopharmacology (Berlin) 122 1995 15 26
277. 1A subtype Eur. J. Pharmacol. 113 1985 463 464 (Pubitemid 16249855)
278. 2C receptor agonists Pharmacol. Biochem. Behav. 69 2001 643 652 (Pubitemid 32758752)
279. F.X. Vollenweider, P.A. Csomor, B. Knappe, M.A. Geyer, and B.B. Quednow The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy volunteers depend on interstimulus interval Neuropsychopharmacology 32 2007 1876 1887 (Pubitemid 47258517)
280. F.X. Vollenweider, and M. Kometer The neurobiology of psychedelic drugs: implications for the treatment of mood disorders Nat. Rev. Neurosci. 11 2010 624 651
281. F.X. Vollenweider, K.L. Leenders, C. Scharfetter, P. Maguire, O. Stadelmann, and J. Angst Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis Neuropsychopharmacology 16 1997 357 372 (Pubitemid 27211734)
282. F.X. Vollenweider, M.F.I. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action NeuroReport 9 1998 3897 3902 (Pubitemid 29189323)
283. 1 dopamine receptors Psychopharmacology 118 1995 401 409
284. F.J. White, and J.B. Appel LSD and lisuride: differentiation of their neuropharmacological actions Science 216 1982 535 537 (Pubitemid 12053929)
285. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats J. Pharmacol. Exp. Ther. 282 1997 699 706 (Pubitemid 27340170)
286. L.L. Wing, G.S. Tapson, and M.A. Geyer 5HT-2 mediation of acute behavioral effects of hallucinogens in rats Psychopharmacology 100 1990 417 425 (Pubitemid 20052435)
287. J.C. Winter Yohimbine-induced stimulus control in the rat Arch. Int. Pharmacodyn. Ther. 235 1978 86 92 (Pubitemid 9066416)
288. J.C. Winter Generalization of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and ipsapirone to yohimbine Pharmacol. Biochem. Behav. 29 1988 193 195 (Pubitemid 18052737)
289. J.C. Winter, J.R. Eckler, and R.A. Rabin Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli Psychopharmacology (Berlin) 172 2004 233 240 (Pubitemid 38388775)
290. 1A receptors Pharmacol. Biochem. Behav. 65 2000 75 82 (Pubitemid 30017998)
291. J.C. Winter, A.K. Kieres, M.D. Zimmerman, C.J. Reissig, J.R. Eckler, T. Ullrich, K.C. Rice, R.A. Rabin, and J.B. Richards The stimulus properties of LSD in C57BL/6 mice Pharmacol. Biochem. Behav. 81 2005 830 837 (Pubitemid 41187816)
292. J.C. Winter, and R.A. Rabin Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus Pharmacol. Biochem. Behav. 30 1988 617 624 (Pubitemid 19271143)
293. J.C. Winter, and R.A. Rabin Yohimbine as a serotonergic agent: evidence from receptor binding and drug discrimination J. Pharmacol. Exp. Ther. 263 1992 682 689
294. J.C. Winter, K.C. Rice, D.J. Amorosi, and R.A. Rabin Psilocybin-induced stimulus control in the rat Pharmacol. Biochem. Behav. 87 2007 472 480 (Pubitemid 47238403)
295. A.B. Wolbach Jr., H. Isbell, and E.J. Miner Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions Psychopharmacology 3 1962 1 14
296. A.B. Wolbach Jr., E.J. Miner, and H. Isbell Comparision of psilocin with psilocybin, mescaline and LSD-25 Psychopharmacologia (Berlin) 3 1962 219 223
297. D.W. Woolley, and E. Shaw A biochemical and pharmacological suggestion about certain mental disorders Proc. Natl. Acad. Sci. U.S.A. 40 1954 228 231
298. 125I-Lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells J. Neurosci. 5 1985 3178 3183 (Pubitemid 16182599)
299. T. Yamamoto, and S. Ueki Behavioral effects of 2,5-dimethoxy-4- methylamphetamine (DOM) in rats and mice Eur. J. Pharmacol. 32 1975 156 162
300. G.K.W. Yim, T.E. Prah, W.R. Pfister, and D.E. Nichols An economical screen for phenethylamine-type hallucinogens: mouse ear scratching Commun. Psychopharmacol. 3 1979 173 178 (Pubitemid 10129216)
301. 1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampul membranes Mol. Pharmacol. 41 1992 1066 1072 (Pubitemid 23026106)
302. R. Young, R.A. Glennon, and J.A. Rosecrans The hallucinogen DOM as a discriminative stimulus Commun. Psychopharmacol. 4 1981 501 504
303. R. Young, J.A. Rosecrans, and R.A. Glennon Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine Pharmacol. Biochem. Behav. 25 1986 1207 1210 (Pubitemid 17212802)